SCHEMBL7310883

SCHEMBL7310883

COC(=O)Cc1ccc(OC)cc1C(C)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
HPGD P15428 4/20 0.51
CYP3A4 P08684 2/20 0.51
MAPK1 P28482 1/20 0.51
KDM4E B2RXH2 6/20 0.51
HSD17B10 Q99714 2/20 0.44
AKR1C3 P42330 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.42
MAOB P27338 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9952903 0.87 KDM4E (0.54) ALDH1A1HPGDCYP3A4KDM4EHSD17B10
SCHEMBL6590821 0.87 ALDH1A1 (0.56) ALDH1A1HPGDCYP3A4MAPK1KDM4E
SCHEMBL7314126 0.85 HSD17B10 (0.61) ALDH1A1HPGDCYP3A4MAPK1KDM4E
SCHEMBL14466515 0.83 ALDH1A1 (0.58) ALDH1A1HPGDCYP3A4MAPK1KDM4E
SCHEMBL14864226 0.81 ALDH1A1 (0.56) ALDH1A1HPGDCYP3A4MAPK1KDM4E
SCHEMBL3918324 0.80 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10AKR1C3
SCHEMBL30336005 0.80 POLB (0.64) ALDH1A1HPGDCYP3A4MAPK1KDM4E
SCHEMBL2436724 0.80 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10AKR1C3
SCHEMBL30046118 0.80 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10AKR1C3
SCHEMBL10112008 0.80 ALDH1A1 (0.54) ALDH1A1HPGDCYP3A4MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed